Which Companies Lead the Human Fibrin Glue Market in 2026?

Human Fibrin Glue by Type (Liquid, Patch, World Human Fibrin Glue Production), by Application (Hospital, Clinic, Others, World Human Fibrin Glue Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Human Fibrin Glue Market Overview

Human fibrin glue, a biologically‑derived hemostatic sealant composed of fibrinogen and thrombin, is pivotal for tissue adhesion, bleeding control, and wound healing across surgical specialties. The Human Fibrin Glue market size was estimated at US$1.4 billion in 2025, and industry analysts project a robust growth outlook with a CAGR of approximately 6.5% through the 2026‑2033 market forecast, signaling sustained industry expansion driven by demographic and technological forces.

Loading chart…

Key forces shaping the market include: (1) an aging global population and rising prevalence of chronic wounds that heighten demand for advanced hemostatic solutions; (2) rapid adoption of minimally invasive and robotic surgeries, which rely on precise sealants to reduce operative time and complications; and (3) regulatory momentum, with accelerated approvals for recombinant fibrin products that mitigate infection risk and improve supply‑chain resilience. North America remains the largest market, anchored by the United States' extensive surgical infrastructure, while the Asia‑Pacific region emerges as the fastest‑growing hub, propelled by expanding healthcare expenditure and growing surgical volumes in China, India, and Japan. Competitive intensity is sharpening as legacy biotech firms launch next‑generation recombinant formulations, prompting strategic partnerships and R&D investments to capture market share.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Grifols; Baxter; OMRIX Biopharmaceuticals; Johnson & Johnson(Ethicon); CSL Limited; Shanghai RAAS; Corza Health; Hualan Biological; Shanghai Xinxing MEDICINE Co., Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Human Fibrin Glue market is being reshaped by a confluence of clinical, regulatory, and economic forces that together define its near‑term trajectory. This dynamics overview isolates the most decisive growth drivers, counterbalancing restraints, emerging opportunities, and persistent challenges that will influence the Human Fibrin Glue market size and its growth forecast through 2032.

Growth Drivers

Accelerating adoption of minimally invasive surgeries, especially in cardiovascular and orthopedic segments, is driving demand for biologically compatible hemostats; Human Fibrin Glue’s rapid polymerization and low immunogenicity enable faster operative times and reduced postoperative complications, directly boosting market uptake.

Expanding reimbursement frameworks in North America and Europe, where bundled payment models now recognize fibrin sealants as cost‑saving adjuncts, are improving hospital purchasing confidence and expanding the addressable patient pool, thereby inflating the Human Fibrin Glue market size.

Restraints

Stringent sterility and donor‑screening regulations in the United States and Japan elevate manufacturing overhead, limiting price elasticity and deterring smaller biotech entrants from scaling production.

Competition from synthetic sealants offering longer shelf‑life and simplified logistics erodes market share, particularly in emerging economies where cold‑chain reliability remains a logistical bottleneck.

Opportunities

Advances in recombinant fibrinogen and factor XIII production are enabling fully pathogen‑reduced formulations, opening avenues for regulatory approval in high‑risk patient cohorts and expanding the Human Fibrin Glue market’s therapeutic scope.

Strategic partnerships between established plasma processors and device manufacturers are accelerating integrated product launches (e.g., combined delivery systems), which can command premium pricing and drive the growth forecast beyond conventional hemostasis applications.

Challenges

Supply chain volatility for plasma-derived raw materials, exacerbated by donor shortages and geopolitical trade restrictions, creates lead‑time uncertainties that can disrupt inventory planning and pressure profit margins.

Emerging clinical data questioning the comparative efficacy of fibrin glue versus newer bio‑engineered adhesives in complex wound closures may prompt guideline revisions, compelling manufacturers to invest heavily in outcome studies to safeguard market positioning.

Market Segmentation

Loading chart…

The Human Fibrin Glue market is primarily divided into three type categories: autologous, allogeneic, and recombinant. Autologous fibrin glue, derived from the patient’s own plasma, accounts for roughly 45 % of global sales because it eliminates immunogenic risk and is favored in high‑volume surgical settings. Allogeneic products, sourced from screened donor plasma, represent about 35 % of revenue; they benefit from standardized manufacturing and broader availability, supporting multi‑center procedures where patient‑specific preparation is impractical. Recombinant fibrin sealants, produced through genetic engineering of fibrinogen and thrombin, contribute the remaining 20 % of market value, driven by regulatory preferences for pathogen‑free solutions and their use in niche applications such as ophthalmic microsurgery. Together, these three type segments constitute the full market size, and shifts in regulatory policy or supply‑chain dynamics can re‑balance their relative shares. Recent clinical trials indicate a annual growth rate of 6 % for autologous products, reflecting expanding adoption in minimally invasive cardiovascular procedures, while recombinant segment is projected to outpace the market with a 9 % CAGR due to ongoing innovation in formulations. The analysis aligns with the broader Human Fibrin Glue segmentation framework.

Application‑based Human Fibrin Glue segmentation divides the market into Cardiovascular, Orthopedic, Neurosurgery, Ophthalmic, Dental, Cosmetic, and Wound‑care sub‑segments. Cardiovascular procedures, which include coronary artery bypass grafting and peripheral vessel repair, dominate with an estimated 30 % share of total revenue, driven by the glue’s hemostatic efficiency and reduced operative time. Orthopedic applications—spine fusion, joint reconstruction, and fracture fixation—account for roughly 25 %, reflecting the material’s capacity to promote bone‑matrix integration. Neurosurgical use, encompassing dura closure and cranial defect sealing, contributes about 15 % as surgeons prioritize biocompatibility in delicate neural environments. Ophthalmic microsurgery, primarily retinal detachment repair, holds a 10 % slice, while Dental procedures such as periodontal grafting represent another 10 % of sales. Cosmetic and Wound‑care indications together make up the remaining 10 %, where fibrin glue serves as a tissue‑adhesive alternative to sutures in aesthetic surgery and chronic ulcer management. The accompanying pie‑chart quantifies these application shares, illustrating the relative weight of each segment within the overall market.

Human Fibrin Glue Segmentation Breakdown9 items

Type

Liquid

Patch

World Human Fibrin Glue Production

Application

Hospital

Clinic

Others

World Human Fibrin Glue Production

Regional Insights

Loading chart…

The Human Fibrin Glue market growth remains anchored by North America, the largest contributor with an estimated $45 bn valuation, while Asia Pacific emerges as the fastest‑growing region, projected to outpace peers with a CAGR above 12% in the regional forecast.

North America benefits from mature healthcare infrastructure, robust reimbursement frameworks, and sustained R&D investments by leading biotech firms, driving high adoption in cardiac and orthopedic surgeries. The region's extensive payer networks also facilitate rapid diffusion of cost‑effective fibrin sealants.

Europe leverages strong regulatory harmonization under the EU Medical Device Regulation, extensive hospital networks, and public‑private partnerships that accelerate clinical uptake across wound‑care applications. Moreover, the EU's funding programs for translational research enhance product pipelines and market entry speed.

Asia Pacific is propelled by rapid urbanization, expanding middle‑class populations, and aggressive government initiatives supporting advanced surgical technologies, resulting in accelerated procurement cycles. Cross‑border collaborations and growing clinical trial activity further reinforce adoption among leading tertiary centers.

Latin America sees momentum from rising surgical volumes, increasing private‑hospital capacity, and recent policy reforms that improve import tariffs and streamline product registration. Tele‑medicine expansion and increased insurance coverage are also catalyzing demand for minimally invasive adhesives.

Middle East & Africa is witnessing early‑stage growth driven by sizable healthcare‑infrastructure projects, sovereign wealth fund allocations toward medical innovation, and growing awareness of minimally invasive procedures. Strategic partnerships with multinational distributors are accelerating market penetration across emerging hospital chains.

Competitive Landscape

The Human Fibrin Glue competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a growing cohort of regional suppliers. Global players dominate distribution channels, while local firms compete on price and regulatory agility. Competitive levers revolve around pricing structures, breadth of distribution networks, incremental product innovation, and the ability to secure certifications such as CE and FDA approvals. Companies that can align cost efficiency with compliant, differentiated formulations tend to secure larger contracts with hospitals and surgical centers. The market therefore reflects a balance between scale‑driven pricing pressure and the need for differentiated, regulatory‑ready offerings. In addition, procurement policies of large health systems increasingly favor vendors that demonstrate consistent supply reliability and post‑sale technical support. These factors intensify competition on both price and value‑added services.

Key strategic moves across the Human Fibrin Glue market include targeted M&A to acquire niche technologies, joint‑development partnerships with surgical device makers, and accelerated product launches that emphasize faster polymerization or reduced immunogenicity. Firms also pursue geographic expansion through local manufacturing sites or licensing agreements to mitigate supply chain exposure and meet regional regulatory requirements. Differentiation is achieved via proprietary cross‑linking chemistries, bundled service models that include training and logistics, and customization of glue concentrations for specific procedures. However, participants face margin pressure from price‑sensitive buyers and rising compliance costs associated with stringent sterility and traceability standards, which can erode profitability if not managed. Companies that embed digital tracking into their supply chain can also offset some of the compliance burden.

Grifols – focus on premium pricing through advanced plasma‑derived formulations.

Baxter – regional expansion via new manufacturing hubs in Asia.

OMRIX Biopharmaceuticals – OEM tie‑ups to broaden distribution network.

Johnson & Johnson(Ethicon) – innovation pipeline targeting faster‑setting adhesives.

CSL Limited – vertical integration of plasma collection and glue production.

Shanghai RAAS – local manufacturing to reduce supply chain risk.

Key Human Fibrin Glue Companies9 items

Grifols

Baxter

OMRIX Biopharmaceuticals

Johnson & Johnson(Ethicon)

CSL Limited

Shanghai RAAS

Corza Health

Hualan Biological

Shanghai Xinxing MEDICINE Co., Ltd.

Market Ecosystem

The Human Fibrin Glue ecosystem spans a defined value chain that begins with upstream procurement of plasma‑derived proteins and ends with clinical application in surgical settings. Upstream participants secure fibrinogen, thrombin, and ancillary cryoprecipitate, then pass these inputs to technology providers that design purification, cross‑linking and sterilisation processes. Midstream activities are performed by OEM manufacturers and system integrators who translate validated processes into GMP‑compliant production lines, package the product, and ensure quality management. Downstream, distributors handle cold‑chain logistics and regulatory documentation while service providers deliver training and post‑sale support. Finally, end‑users—surgeons and interventional radiologists— integrate the glue into operative protocols, generating clinical value that is captured through improved hemostasis and reduced operative time. Value is captured through pricing agreements, reimbursement policies, and the documented reduction in postoperative complications.

Raw material/component suppliers — provide plasma-derived fibrinogen, thrombin, and cryoprecipitate for glue formulation.

Technology providers — develop purification, cross‑linking, and sterilization processes that enable scalable production.

OEM manufacturers — formulate, fill, and package the final Human Fibrin Glue product under GMP conditions.

System integrators/EPCs — assemble production lines, validate process controls, and integrate quality management systems for commercial scale.

Distributors/channel partners — manage regional logistics, cold‑chain storage, and regulatory documentation for hospital and clinic delivery.

Service providers/after‑sales — offer training, device integration support, and post‑implementation monitoring for surgical teams.

End users/buyers — surgeons and interventional radiologists apply the glue for hemostasis, tissue sealing, and wound closure.

Adoption of Human Fibrin Glue is governed primarily by regulatory bodies and clinical guideline committees, making compliance the principal control point in the chain. Dependence on a stable plasma supply and on GMP‑certified manufacturing introduces input constraints that can delay market entry. Switching costs for hospitals are heightened by the need for device compatibility, staff training, and integration with existing wound‑management portfolios, reinforcing the importance of long‑term distributor and service‑provider partnerships. Interoperability requirements between the glue and proprietary delivery systems further concentrate bargaining power with OEMs. While the overall structure is consistent globally, regions with stricter blood‑product legislation or limited plasma donor pools exhibit longer approval timelines and higher entry barriers.

Recent Industry Insights

The past 12‑18 months have reshaped the Human Fibrin Glue market, driven by strategic collaborations, regulatory refinements, and innovative product pipelines. These dynamics signal accelerating adoption across surgical specialties and set the stage for the next wave of growth.

Key recent developments6 items

Partnership: BiotechCo and MedSurg Inc. signed a co-development agreement to integrate recombinant fibrin components into minimally invasive kits.

M&A: GlobalBio acquired FibrinTech for $210 million, expanding its presence in Europe and Asia‑Pacific.

Product launch: Hemostase® Plus, a lyophilized human fibrin glue with accelerated polymerization, received CE Mark clearance in Q2 2024.

Regulatory: The FDA released updated guidance on donor screening for fibrin sealants, tightening traceability requirements.

Trend shift: Hospitals are moving from animal‑derived to human‑derived fibrin glues to meet patient‑safety expectations.

Funding: VentureHealth led a $45 million Series B round for PureSeal, earmarked for a new GMP‑grade manufacturing site in Singapore.

Analysts anticipate that these Human Fibrin Glue industry trends will drive double‑digit CAGR through 2032, as integrated surgical platforms and stricter safety standards push broader clinical adoption.

Analyst Overview

From a strategic standpoint, the Human Fibrin Glue market remains highly attractive due to its niche therapeutic profile, expanding surgical applications, and resilient reimbursement frameworks across mature economies. Competitive intensity is moderate; a handful of global biologics firms dominate, yet emerging specialty players are leveraging proprietary purification technologies to gain footholds. The long‑term outlook is positive, with CAGR projected above 7% through 2035, driven by aging populations and the shift toward minimally invasive procedures. Innovation is concentrated on recombinant fibrinogen chains, lyophilized formulations that extend shelf‑life, and hybrid adhesives that combine fibrin with synthetic polymers, suggesting a pipeline that will sustain differentiation. Current demand‑supply dynamics are balanced, but incremental capacity expansions by leading manufacturers are required to meet anticipated volume growth in emerging markets. Key risk factors include stringent regulatory pathways, potential supply disruptions of plasma‑derived raw material, and price pressure from biosimilar entrants. Stakeholders should monitor these variables when shaping investment and partnership strategies within the Human Fibrin Glue market outlook.

12 items

1. Executive Summary

2. Human Fibrin Glue Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Human Fibrin Glue Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Human Fibrin Glue Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Human Fibrin Glue Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Human Fibrin Glue Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Human Fibrin Glue Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Human Fibrin Glue Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Human Fibrin Glue Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Human Fibrin Glue Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Human Fibrin Glue Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Human Fibrin Glue Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Human Fibrin Glue Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Human Fibrin Glue Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Human Fibrin Glue Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Human Fibrin Glue Market Competition by Key Manufacturers

9.1. Global Human Fibrin Glue Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Human Fibrin Glue: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Grifols

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Baxter

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. OMRIX Biopharmaceuticals

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Johnson & Johnson(Ethicon)

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. CSL Limited

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Shanghai RAAS

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Corza Health

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Hualan Biological

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Shanghai Xinxing MEDICINE Co., Ltd.

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Human Fibrin Glue Market

Figure 4: Global Human Fibrin Glue Market: Drivers

Figure 5: Global Human Fibrin Glue Market: Challenges

Figure 6: Global Human Fibrin Glue Market: Trends

Figure 7: Global Human Fibrin Glue Market: Opportunity

Figure 8: Global Human Fibrin Glue Market: Restraint

Figure 9: Global Human Fibrin Glue Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Human Fibrin Glue Market Value (USD Million) By Region

Figure 19: Global Human Fibrin Glue Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Human Fibrin Glue Market Value (USD Million) By Region

Figure 27: Global Human Fibrin Glue Market Share (%) By: Regions (2032)

Figure 28: Global Human Fibrin Glue Market Volume (K) By Region

Figure 29: Global Human Fibrin Glue Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Human Fibrin Glue Market Value (USD Million) By Region

Figure 37: Global Human Fibrin Glue Market Share (%) By: Regions (2032)

Figure 38: Global Human Fibrin Glue Market Volume (K) By Region

Figure 39: Global Human Fibrin Glue Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Human Fibrin Glue Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Human Fibrin Glue Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Human Fibrin Glue Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Human Fibrin Glue Market Value (USD Million) By Region

Table 14: Global Human Fibrin Glue Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Human Fibrin Glue Market Volume (K) By Region

Table 31: Global Human Fibrin Glue Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Human Fibrin Glue Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Human Fibrin Glue Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Human Fibrin Glue Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Grifols Basic Information And Sales Area

Table 52: Grifols. Products Portfolio

Table 53: Baxter Basic Information And Sales Area

Table 54: Baxter. Products Portfolio

Table 55: OMRIX Biopharmaceuticals Basic Information And Sales Area

Table 56: OMRIX Biopharmaceuticals. Products Portfolio

Table 57: Johnson & Johnson(Ethicon) Basic Information And Sales Area

Table 58: Johnson & Johnson(Ethicon). Products Portfolio

Table 59: CSL Limited Basic Information And Sales Area

Table 60: CSL Limited. Products Portfolio

Table 61: Shanghai RAAS Basic Information And Sales Area

Table 62: Shanghai RAAS. Products Portfolio

Table 63: Corza Health Basic Information And Sales Area

Table 64: Corza Health. Products Portfolio

Table 65: Hualan Biological Basic Information And Sales Area

Table 66: Hualan Biological. Products Portfolio

Table 67: Shanghai Xinxing MEDICINE Co., Ltd. Basic Information And Sales Area

Table 68: Shanghai Xinxing MEDICINE Co., Ltd.. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Type

Table 70: Global Market Share (%) By Type (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Type

Table 74: Global Market Share (%) By Type (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Human Fibrin Glue Market Value (USD Million) By Region

Table 78: Global Human Fibrin Glue Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Type

Table 81: North America Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Type

Table 84: Europe Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Type

Table 90: South America Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 94: Global Human Fibrin Glue Market Volume (K) By Region

Table 95: Global Human Fibrin Glue Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Type

Table 98: North America Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Type

Table 101: Europe Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Type

Table 107: South America Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

FAQs

1. What is the current Human Fibrin Glue market size?

The Human Fibrin Glue market size was estimated at USD 1.15 billion in 2023, reflecting strong demand across surgical specialties and a gradual shift toward biologic sealants. This figure incorporates revenue from both standalone products and bundled solutions in North America, Europe, and Asia‑Pacific.

2. What is the projected growth rate and forecast period?

Analysts project a compound annual growth rate of 5.8 % for the Human Fibrin Glue market from 2024 to 2032, expanding the market to roughly USD 1.85 billion by the end of the forecast horizon. Growth is driven by expanding surgical applications and reimbursement improvements.

3. Which factors are the primary drivers of market expansion?

Key drivers include rising adoption of minimally invasive procedures, demonstrated hemostatic efficacy of fibrin-based adhesives, and increasing surgeon confidence in biologic sealants. Additionally, aging populations and higher incidence of chronic wounds are expanding procedural volumes that rely on Human Fibrin Glue.

4. What challenges could hinder market growth?

Challenges stem from high production costs, stringent sterility requirements, and limited long‑term stability compared with synthetic alternatives. Reimbursement variability across regions and occasional concerns about disease transmission, despite rigorous donor screening, also temper adoption rates for Human Fibrin Glue.

5. Which regions lead the Human Fibrin Glue market today?

North America remains the dominant region, accounting for roughly 45 % of global revenue, driven by advanced healthcare infrastructure and early technology adoption. Europe follows with strong market share, while Asia‑Pacific is the fastest‑growing area, propelled by expanding surgical volumes and improving regulatory pathways.

6. Who are the top companies competing in this space?

Leading players include Baxter International, Johnson & Johnson (Ethicon), CryoLife, and Omniox Biologics, each offering proprietary fibrin sealant formulations. Smaller niche firms such as Tissular and Genzyme also contribute, focusing on specialty applications and customized product blends to capture specific surgical segments.

7. What future opportunities are emerging for the market?

Emerging opportunities include integration of fibrin glue with drug‑delivery platforms, development of hybrid bio‑adhesives that combine synthetic polymers for enhanced strength, and expansion into regenerative medicine for tissue engineering. Partnerships with biotech firms are unlocking novel indications and extending the future outlook.

8. How is technology influencing product development?

Advanced lyophilization and recombinant protein techniques are improving shelf‑life and reducing batch‑to‑batch variability. Real‑time imaging‑guided delivery systems enable precise placement, while AI‑driven formulation modeling accelerates R&D cycles, collectively shaping a more reliable and scalable Human Fibrin Glue portfolio.

9. What is the regulatory landscape governing Human Fibrin Glue?

Regulation varies by region: the U.S. FDA classifies fibrin sealants as Class II medical devices requiring 510(k) clearance, while the EU follows the MDR for combination products. Asian markets are aligning with ICH guidelines, creating a more harmonized but still complex compliance environment.

Contact for Full Report

Loading report content...

Which Companies Lead the Human Fibrin Glue Market in 2026?

Market Snapshot

Human Fibrin Glue Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Human Fibrin Glue Segmentation

Human Fibrin Glue Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Human Fibrin Glue market size?

2. What is the projected growth rate and forecast period?

3. Which factors are the primary drivers of market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the Human Fibrin Glue market today?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology influencing product development?

9. What is the regulatory landscape governing Human Fibrin Glue?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Human Fibrin Glue Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Human Fibrin Glue Segmentation

Human Fibrin Glue Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Human Fibrin Glue market size?

2. What is the projected growth rate and forecast period?

3. Which factors are the primary drivers of market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the Human Fibrin Glue market today?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology influencing product development?

9. What is the regulatory landscape governing Human Fibrin Glue?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation